Long-term Benefits for the Quality of Life After Video-assisted Thoracoscopic Lobectomy in Patients With Lung Cancer

Sugiura, Hiroshi; Morikawa, Toshiaki; Kaji, Mitsuhito; Sasamura, Yuji; Kondo, Satoshi; Katoh, Hiroyuki

doi:10.1097/00129689-199912000-00007

Cited by 138 publications

(93 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thus, despite the large series published, and although there are no prospective randomized studies comparing survival after open and thoracoscopic surgery, there is no evidence to support a difference. In their opinion, and according to published series of extensive experience with thoracoscopic lobectomy reporting stage-specific survival, this was proven to be at least equivalent to that seen in historical series [74,76,85,[101][102][103].…”

Section: Vats Major Pulmonary Resectionsmentioning

confidence: 75%

“…Several nonrandomized series also reported less postoperative pain after VATS [74, 86, 87, 90 -98]. Sugiura et al [85] reported a shorter time that an epidural catheter was needed, while Demmy and Curtis [86] reported that pain 3 weeks postoperatively was dramatically better, thus stating that VATS lobectomy is less painful and may offer faster recovery, especially for the frail or high-risk patient.…”

Section: Vats Major Pulmonary Resectionsmentioning

confidence: 98%

“…Other fields of comparison are: (a) the duration of the surgical procedure, which proved to be equivalent for experienced surgeons [77][78][79][80]85] with a lower mean blood loss in favor of the VATS procedure [86,87,81]; (b) the length of the postoperative course, which, according to the recent review by McKenna et al [84], appears to be the same or shorter for the endoscopic approach; and (c) the overall hospital costs, as measured by anesthesia charges, laboratory charges, and hospital charges, which are also reported to be lower with the VATS approach [88].…”

Section: Vats Major Pulmonary Resectionsmentioning

confidence: 99%

“…In terms of postoperative pain, all the available randomized prospective reports [77,85,89], except for a paper by Kirby et al [78], demonstrated a general advantage of the endoscopic procedure over muscle-sparing thoracotomy [89]. Several nonrandomized series also reported less postoperative pain after VATS [74, 86, 87, 90 -98].…”

Section: Vats Major Pulmonary Resectionsmentioning

confidence: 99%

See 3 more Smart Citations

Indications and Developments of Video-Assisted Thoracic Surgery in the Treatment of Lung Cancer

Solli

Spaggiari

2007

The Oncologist

View full text Add to dashboard Cite

After completing this course, the reader will be able to:1. Discuss the role of thoracoscopy in the evaluation of pulmonary nodules and pleural effusion.2. Describe the role of thoracoscopy in the staging of lung cancer.3. Discuss the role of thoracoscopy in surgical resection of early-stage lung cancer.Access and take the CME test online and receive 1 AMA PRA Category 1 Credit ™ at CME.TheOncologist.com CME CME ABSTRACTThe term video-assisted thoracic surgery (VATS) is used to describe a modern minimally invasive surgical technique that nowadays represents a valid alternative to open procedures (i.e., thoracotomy) for many chest diseases. The VATS approach is presently used in many intrathoracic disorders, but while well established in benign chest disease, its role continues to evolve regarding the management of lung cancer. It is currently considered for the evaluation and treatment of suspected (or known) pleural effusion and in the diagnosis of indeterminate pulmonary nodules, and it has a complementary role to standard cervical mediastinoscopy in the invasive staging of mediastinal lymph nodes. It has also become an accepted approach for resection of peripheral early-stage lung cancer (stage I) in many centers worldwide and considerable experience has been accumulated in respect to this field, but absolute indications have yet to be firmly defined. This paper reviews indications and current data regarding minimally invasive approaches for the staging and treatment of lung cancer.

show abstract

Section: Vats Major Pulmonary Resectionsmentioning

confidence: 75%

Section: Vats Major Pulmonary Resectionsmentioning

confidence: 98%

Section: Vats Major Pulmonary Resectionsmentioning

confidence: 99%

Section: Vats Major Pulmonary Resectionsmentioning

confidence: 99%

See 2 more Smart Citations

Indications and Developments of Video-Assisted Thoracic Surgery in the Treatment of Lung Cancer

Solli

Spaggiari

2007

The Oncologist

View full text Add to dashboard Cite

show abstract

“…The assumed benefits from VATS over open technique includes: shorter hospital stay, less postoperative pain, cosmesis, less blood loss, earlier resumption of daily activities, better tolerance to postoperative chemotherapy (1)(2)(3)(4)(5)(6)(7)(8)(9). In traditional VATS surgery, the instruments and the thoracoscope enter the thoracic cavity through two to four operating ports on the lateral chest wall, which can cause chronic pain and chest wall numbness.…”

Section: Introductionmentioning

confidence: 99%

Subxiphoid uniportal lobectomy

et al. 2017

View full text Add to dashboard Cite

Video-assisted thoracic surgery (VATS) surgery has seen an evolution from multiple ports to uniportal and finally subxiphoid uniportal recently. In traditional VATS surgery, the instruments and the thoracoscope enter the thoracic cavity through two to four operating ports on the lateral chest wall, which can cause chronic pain and chest wall numbness. However single-portal VATS surgery could potentially cause similar problems as the port is placed in between the ribs. In March 2015 Liu et al. reported a VATS bilateral pulmonary metastasectomy and right middle lobectomy via a subxiphoid uniportal technique.The advantage of the uniportal subxiphoid approach is the ability to use different size of instruments and freedom of movement as there is no limitation by the ribs. Post-operative pain typically experienced due to bruising of the intercostal nerves is also avoided in this approach. Shanghai Pulmonary hospital has taken VATS surgery to the next level with subxiphoid uniportal VATS (SVATS) lung resection, whereby this method is performed in large volumes of cases. Here we describe our experience of a uniportal subxiphoid VATS right middle lobectomy using the Shanghai technique, the first in the UK. A uniportal sub-xiphoid lobectomy was performed on a 62-year-old lifelong smoker male patient with a histological diagnosis of right middle lobe adenocarcinoma, measuring 1.5 cm and radiological staging of T1aN0M0. We have been performing microlobectomies in our institution (with the utility port placed in the subxiphoid region) which is technically similar to this approach. This is the first subxiphoid uniportal lobectomy performed in the UK. The operation was done successfully and the patient was discharged home 2 days later without any complications.

show abstract

Surgery for local and locally advanced non-small cell lung cancer

Manser

Wright

Hart

et al. 2005

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Conclusions about the efficacy of surgery for local and loco-regional NSCLC are limited by the small number of participants studied to date and potential methodological weaknesses of trials. Current evidence suggests that lung cancer resection combined with complete mediastinal lymph node dissection is associated with a small to modest improvement in survival compared with lung cancer resection combined with systematic sampling of mediastinal nodes in patients with stage I to IIIA NSCLC.

show abstract

Long-term Benefits for the Quality of Life After Video-assisted Thoracoscopic Lobectomy in Patients With Lung Cancer

Cited by 138 publications

References 0 publications

Indications and Developments of Video-Assisted Thoracic Surgery in the Treatment of Lung Cancer

Indications and Developments of Video-Assisted Thoracic Surgery in the Treatment of Lung Cancer

Subxiphoid uniportal lobectomy

Surgery for local and locally advanced non-small cell lung cancer

Contact Info

Product

Resources

About